QIAGEN N.V. (QGEN) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2025-12-31..
- Stock-based compensation / revenue · 12 months: Value 2.41%; Formula and calculation Share-based compensation / revenue. Period ending 2025-12-31..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2025-12-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2025-12-31. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 2.41% | Share-based compensation / revenue. Period ending 2025-12-31. $50.40M ÷ $2.09B × 100 ≈ 2.41% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 2.09B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 50.40M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 465.85M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | (m) | $2.09B | $50.40M | $465.85M | (m) | (m) | 2.41% | (m) | (m) |
| 2024-12-31 | (m) | $1.98B | $43.63M | $97.71M | (m) | (m) | 2.21% | (m) | (m) |
| 2023-12-31 | (m) | $1.97B | $47.10M | $409.94M | $53.41M | (m) | 2.40% | 7.68× | Reported |
| 2022-12-31 | (m) | $2.14B | $49.51M | $531.46M | $58.36M | (m) | 2.31% | 9.11× | Reported |
| 2021-12-31 | (m) | $2.25B | $38.39M | $630.08M | $54.48M | (m) | 1.71% | 11.57× | Reported |
| 2020-12-31 | (m) | $1.87B | $40.94M | $386.43M | $71.32M | (m) | 2.19% | 5.42× | Reported |
| 2019-12-31 | (m) | $1.53B | $65.89M | $-26.14M | $74.19M | (m) | 4.32% | -0.35× | Reported |
| 2018-12-31 | (m) | $1.50B | $40.11M | $266.58M | $67.29M | (m) | 2.67% | 3.96× | Reported |
| 2017-12-31 | (m) | $1.42B | $34.44M | $153.42M | $49.69M | (m) | 2.43% | 3.09× | Reported |
| 2016-12-31 | (m) | $1.34B | $28.29M | $98.83M | $39.02M | (m) | 2.11% | 2.53× | Reported |
| 2015-12-31 | (m) | $1.28B | $27.57M | $175.69M | $37.40M | (m) | 2.15% | 4.70× | Reported |
| 2014-12-31 | (m) | $1.34B | $42.19M | $160.82M | $39.33M | (m) | 3.14% | 4.09× | Reported |
| 2013-12-31 | (m) | $1.30B | $37.94M | $63.33M | $30.88M | (m) | 2.91% | 2.05× | Reported |
| 2012-12-31 | (m) | $1.25B | $25.36M | $169.81M | $23.45M | (m) | 2.02% | 7.24× | Reported |
| 2011-12-31 | (m) | $1.17B | $19.54M | $99.59M | $25.36M | (m) | 1.67% | 3.93× | Reported |
| 2010-12-31 | (m) | $1.09B | $13.59M | $188.54M | $27.82M | (m) | 1.25% | 6.78× | Reported |
| 2009-12-31 | (m) | $1.01B | $9.75M | $180.21M | $29.64M | (m) | 0.97% | 6.08× | Reported |
| 2008-12-31 | (m) | $892.98M | $9.79M | $145.66M | $37.53M | (m) | 1.10% | 3.88× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.